-
JANSSEN PHARMACEUTIC, et al v. DR. REDDY'S LABORATO, et al DC
- 2:03-cv-06185
- D.N.J.
- Judge: Jose L. Linares +1
- Filed: 12/30/2003
- Closed: 08/24/2007
- Latest Docket Entry: 08/24/2007
- PACER
- Docket updated daily
2
Plaintiffs
2
Defendants
1
Accused
Product
1
Patent-in-Suit
1,334
Days in
Litigation
-
JANSSEN PHARMACEUTIC, et al v. DR. REDDY'S LABORATO, et al DC
- 2:03-cv-06185
- D.N.J.
- Judge: Jose L. Linares +1
- Filed: 12/30/2003
- Closed: 08/24/2007
- Latest Docket Entry: 08/24/2007
- PACER
- Docket updated daily
Cause of Action
Willful Patent Infringement
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
Claim # | Claim Text | Outcome |
---|---|---|
1 |
A chemical compound having the formula ##STR17## or a pharmaceutically acceptable acid addition salt thereof, wherein R is hydrogen or C.sub.1-6 alkyl; R.sup.1 and R.sup.2 are each independently members selected from the group consisting of
view more
|
Enforceable and Valid (103)
Entry 94 |
2 |
A chemical compound according to claim 1, wherein Q is a radical of formula (a) wherein R.sup.3 is hydrogen, halo, C.sub.1-6 alkyl, C.sub.1-6 alkyloxy, trifluoromethyl, hydroxy, amino or azido and R.sup.4 is hydrogen; or Q is a radical of formula
view more
|
Enforceable and Valid (103)
Entry 94 |
3 |
A chemical compound according to claim 2, wherein R is hydrogen, R.sup.1 is hydrogen or halo and R.sup.2 is hydrogen, halo, hydroxy or C.sub.1-6 alkyloxy.
|
Enforceable and Valid (103)
Entry 94 |
4 |
A chemical compound according to claim 3, wherein Q is a radical of formula (a) wherein R.sup.3 is hydrogen, halo or methyl and Y.sup.1 is O; or Q is a radical of formula (b) wherein --Z--A-- is --S--CH.sub.2 --CH.sub.2 --, --S--(CH.sub.2).sub.3
view more
|
Enforceable and Valid (103)
Entry 94 |
5 |
A chemical compound according to claim 4, wherein R.sup.1 is hydrogen, and R.sup.2 is hydrogen, halo, hydroxy or methoxy.
|
Enforceable and Valid (103)
Entry 94 |
6 |
A chemical compound according to claim 1 wherein the compound is 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetr ahydro-2-methyl-4H-pyrido[1,2-a]-pyrimidin-4-one or
view more
|
Enforceable and Valid (103)
Entry 94 |
7 |
A pharmaceutical composition for treating psychotic diseases, comprising an inert carrier and as an active ingredient a pharmaceutically effective amount of a chemical compound having the formula ##STR20## or a pharmaceutically acceptable acid
view more
|
Enforceable and Valid (103)
Entry 94 |
8 |
A pharmaceutical composition according to claim 7 wherein Q is a radical of formula (a) wherein R.sup.3 is hydrogen, halo, C.sub.1-6 alkyl, C.sub.1-6 alkyloxy, trifluoromethyl, hydroxy, amino or azido and R.sup.4 is hydrogen; or Q is a radical of
view more
|
Enforceable and Valid (103)
Entry 94 |
9 |
A pharmaceutical composition according to claim 8 wherein R is hydrogen, R.sup.1 is hydrogen or halo and R.sup.2 is hydrogen, halo, hydroxy or C.sub.1-6 alkyloxy.
|
Enforceable and Valid (103)
Entry 94 |
10 |
A pharmaceutical composition according to claim 9 wherein Q is a radical of formula (a) wherein R.sup.3 is hydrogen, halo or methyl and Y.sup.1 is O; or Q is a radical of formula (b) wherein --Z--A-- is --S--CH.sub.2 --CH.sub.2 --,
view more
|
Enforceable and Valid (103)
Entry 94 |
11 |
A pharmaceutical composition according to claim 10 wherein R.sup.1 is hydrogen, and R.sup.2 is hydrogen, halo, hydroxy or methoxy.
|
Enforceable and Valid (103)
Entry 94 |
12 |
A pharmaceutical composition according to claim 7 wherein the compound is 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetr ahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one or
view more
|
Enforceable and Valid (103)
Entry 94 |
13 |
A method of treating warm-blooded animals suffering from psychotic diseases which comprises the administration thereto of a pharmaceutically effective amount of a chemical compound having the formula ##STR23## or a pharmaceutical acceptable acid
view more
|
Enforceable and Valid (103)
Entry 94 |
14 |
A method according to claim 13 wherein Q is a radical of formula (a) wherein R.sup.3 is hydrogen, halo, C.sub.1-6 alkyl, C.sub.1-6 alkyloxy, trifluoromethyl, hydroxy, amino or azido and R.sup.4 is hydrogen; or Q is a radical of formula (b)
view more
|
Enforceable and Valid (103)
Entry 94 |
15 |
A method according to claim 14 wherein R is hydrogen, R.sup.1 is hydrogen or halo and R.sup.2 is hydrogen, halo, hydroxy or C.sub.1-6 alkyloxy.
|
Enforceable and Valid (103)
Entry 94 |
16 |
A method according to claim 15 wherein Q is a radical of formula (a) wherein R.sup.3 is hydrogen, halo or methyl and Y.sup.1 is O; or Q is a radical of formula (b) wherein --Z--A-- is --S--CH.sub.2 --CH.sub.2 --, --S--(CH.sub.2).sub.3 --,
view more
|
Enforceable and Valid (103)
Entry 94 |
17 |
A method according to claim 16 wherein R.sup.1 is hydrogen, and R.sup.2 is hydrogen, halo, hydroxy or methoxy.
|
Enforceable and Valid (103)
Entry 94 |
18 |
A method according to claim 13 wherein the compound is 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetr ahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one or
view more
|
Enforceable and Valid (103)
Entry 94 |
-
Infringement
Dr. Reddy's Lab., Inc.
- 1 Detail
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
Generic risperidone tablets | US 4,804,663 A |
1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
|
Infringement
Entry 94
|
Dr. Reddy's Laboratories Ltd.
- 1 Detail
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
Generic risperidone tablets | US 4,804,663 A |
1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
|
Infringement
Entry 94
|